SUN PHARMACEUTICAL IND L (SUNPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading a…

Sun Pharmaceutical Ind L

SUNPHARMA

ROE12.7%
ROCE14.8%
Stock P/E159
Book Value₹93.2
Face Value₹1.00
High / Low₹1,963/1,547
Market Cap₹4,69,406Cr.
Current Price₹1,956
Dividend Yield0.82%
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.[1]It is the largest pharmaceutical company in India.[2]

Quarterly Results

Yearly Results

Balance Sheet

Cash Flows

Last updated at: 21 July 2026 at 4:57:54


Designed & Shipped by Harshit Bansal